[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kala Bio Inc (KALA)

Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
KALA BIO: Q1 Earnings Snapshot

KALA BIO: Q1 Earnings Snapshot

KALA : 1.7800 (+2.89%)
KALA BIO Announces Reverse Stock Split

ARLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- KALA BIO , Inc. (NASDAQ: KALA) (“KALA BIO” or the “Company”), today announced that it intends to effect a reverse stock split of its common...

KALA : 1.7800 (+2.89%)
Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments

SUMMIT, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER ) (“Aterian” or the “Company” ), a consumer products company, today announced separate transactions related to...

FIEE : 4.25 (-1.14%)
BGMS : 1.1000 (+20.88%)
YHC : 0.0525 (-33.54%)
KALA : 1.7800 (+2.89%)
OPGN : 24.7500 (+3.13%)
ATER : 1.2600 (-4.55%)
BTTC : 0.7525 (+1.61%)
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

ARLINGTON, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“ KALA ” or the “ Company ”) today celebrated the landmark Executive Order signed by U.S. President Donald...

TRUFF : 0.0265 (+17.26%)
TRIP.CN : 0.0300 (-14.29%)
KALA : 1.7800 (+2.89%)
KALA BIO: Q4 Earnings Snapshot

KALA BIO: Q4 Earnings Snapshot

KALA : 1.7800 (+2.89%)
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio Inc. (NASDAQ: KALA), a clinical-stage biopharmaceutical company at the forefront of artificial intelligence and cell and gene therapy innovation,...

KALA : 1.7800 (+2.89%)
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live

ARLINGTON, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“Kala” or the “Company”) today announced the initial commercial deployment of the Bionic Intelligence Research...

KALA : 1.7800 (+2.89%)
Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate

AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio’s purpose-built agentic AI platform for the biotechnology industry TORONTO...

TRUFF : 0.0265 (+17.26%)
TRIP.CN : 0.0300 (-14.29%)
KALA : 1.7800 (+2.89%)
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents

Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the agentic R&D paradigm Researgency.ai is bringing to life sciences with Kala Bio (KALA)Toronto, Ontario--(Newsfile...

KALA : 1.7800 (+2.89%)
Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates

ARLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) announces that it is ready to ship its first commercial AI product in approximately 14 days, transforming the Company...

KALA : 1.7800 (+2.89%)

Barchart Exclusives

This Wannabe Dividend King Had a Tough H1. Expect Some Relief in H2.
The dividend yield of MCD stock has risen to nearly 2.8%, with McDonald's on the verge of becoming a Dividend King. While not a tempting buy, dividend investors can start accumulating shares at these levels. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.